Vectura Group has appointed Paul Fry as CFO and executive director with effect from 29 October 2018. Paul succeeds Andrew Derodra who leaves the Group and Board on 31 July 2018. Paul joins Vectura from Immunocore, where he has been CFO since January 2017. Paul has significant experience in senior positions in the healthcare and telecommunications sectors. Before joining Immunocore Paul served as director of global finance operations at Vodafone, and prior to that he spent more than 25 years at GlaxoSmithKline (GSK), where he held a number of senior roles including head of global finance services and as CFO for GSK’s Italian Pharmaceutical business.
